Understanding how p53 influences cell development and cancer formation
Mapping p53 dynamics to cell-fate outcomes in reprogramming and oncogenesis
This study is looking at how a protein called p53 helps cells grow and change, especially in cancer, and it aims to find better ways to turn certain cells back into a more basic, stem cell-like state to improve treatments for cancer and healing.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts Institute of Technology NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project ID | NIH-10906234 on NIH RePORTER |
What this research studies
This research investigates the role of the p53 protein in determining how cells develop and differentiate, particularly in the context of cancer. It explores how certain cells can revert to a stem cell-like state and how this process can be influenced by specific transcription factors. By utilizing advanced 3-D modeling techniques, the study aims to improve the efficiency of cell reprogramming, which could lead to better therapeutic strategies for cancer treatment and regenerative medicine.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with cancers related to p53 mutations or those interested in stem cell therapies.
Not a fit: Patients with stable, non-cancerous conditions or those not affected by p53-related pathways may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for cancer and improved methods for regenerating damaged tissues.
How similar studies have performed: Previous research has shown promising results in reprogramming cells using similar approaches, indicating potential for success in this area.
Where this research is happening
Cambridge, United States
- Massachusetts Institute of Technology — Cambridge, United States (Active)
Researchers
- Principal investigator: Beitz, Adam Matthew — Massachusetts Institute of Technology
- Study coordinator: Beitz, Adam Matthew
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.